5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO + IPI) or NIVO alone Meeting Abstract


Authors: Robert, C.; Long, G. V.; Larkin, J.; Wolchok, J. D.; Hassel, J. C.; Schadendorf, D.; Hodi, F. S.; Lebbé, C.; Grob, J. J.; Grossmann, K.; Wagstaff, J.; Chesney, J.; Butler, M. O.; Bechter, O.; Marquez-Rodas, I.; Pavlick, A. C.; Re, S.; van Dijck, W.; Postow, M. A.; Ascierto, P. A.
Abstract Title: 5-year characterization of complete responses in patients with advanced melanoma who received nivolumab plus ipilimumab (NIVO + IPI) or NIVO alone
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S734
End Page: S735
Language: English
ACCESSION: WOS:000573469101370
DOI: 10.1016/j.annonc.2020.08.1206
PROVIDER: wos
Notes: Meeting Abstract: 1082MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok